Table 2.
Clinical Characteristics of Respondentsa in the CITIES Project, NC 2004–2007
| Clinical Characteristics | Total | |
|---|---|---|
| (N=2663) | % | |
| LDL | ||
| Optimum (≤99 mg/dL) | 641 | 30.9 |
| Near optimum/above optimum (100–129 mg/dL) | 833 | 40.1 |
| Borderline high risk (130–159 mg/dL) | 434 | 20.9 |
| High risk (160–189 mg/dL) | 129 | 6.3 |
| Very high risk (≥190 mg/dL) | 38 | 1.8 |
| HDL | ||
| Preventive (≥60 mg/dL) | 602 | 23.0 |
| Normal (40–59 mg/dL) | 1244 | 47.6 |
| High risk (<40 mg/dL) | 770 | 29.4 |
| Total cholesterol | ||
| Normal (≤199 mg/dL) | 1649 | 62.7 |
| Moderate risk (200–239 mg/dL) | 741 | 28.2 |
| High risk (≥240 mg/dL) | 240 | 9.1 |
| Triglyceride | ||
| Optimum (≤149 mg/dL) | 1385 | 52.7 |
| Borderline high risk (150–199 mg/dL) | 479 | 18.2 |
| High risk (≥200 mg/dL) | 762 | 29.0 |
| Blood glucose | ||
| Normal (50–149) | 2359 | 89.9 |
| Moderate risk (150–199 mg/dL) | 174 | 6.6 |
| High risk (≥200 mg/dL) | 92 | 3.5 |
| BMI | ||
| Underweight (≤18.5) | 24 | 0.9 |
| Normal (18.5–24.9999) | 436 | 16.5 |
| Overweight (25–29.9999) | 885 | 33.5 |
| Obese (≥30) | 1295 | 49.1 |
| Systolic BP | ||
| Controlled (normal) (≤140 mm Hg) | 1485 | 56.5 |
| Uncontrolled (≥140 mm Hg) | 1141 | 43.5 |
| Diastolic BP | ||
| Controlled (normal) (≤90 mm Hg) | 2022 | 77.2 |
| Uncontrolled (≥90 mm Hg) | 598 | 22.8 |
| Combined systolic and diastolic BP | ||
| Controlled (normal) | 2121 | 81.5 |
| Uncontrolled | 480 | 18.5 |
Abbreviations: BMI, body mass index; BP, blood pressure; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein.
a
Totals do not sum to the sample size due to missing data.